162 related articles for article (PubMed ID: 22819534)
1. KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.
Liu X; Gomez-Pinillos A; Loder C; Carrillo-de Santa Pau E; Qiao R; Unger PD; Kurek R; Oddoux C; Melamed J; Gallagher RE; Mandeli J; Ferrari AC
Am J Pathol; 2012 Sep; 181(3):1007-16. PubMed ID: 22819534
[TBL] [Abstract][Full Text] [Related]
2. KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations.
Agell L; Hernández S; de Muga S; Lorente JA; Juanpere N; Esgueva R; Serrano S; Gelabert A; Lloreta J
Mod Pathol; 2008 Dec; 21(12):1470-8. PubMed ID: 19020536
[TBL] [Abstract][Full Text] [Related]
3. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers.
Chiam K; Ryan NK; Ricciardelli C; Day TK; Buchanan G; Ochnik AM; Murti K; Selth LA; ; Butler LM; Tilley WD; Bianco-Miotto T
Prostate; 2013 Jan; 73(2):182-93. PubMed ID: 22782870
[TBL] [Abstract][Full Text] [Related]
5. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
6. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
[TBL] [Abstract][Full Text] [Related]
8. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
[TBL] [Abstract][Full Text] [Related]
9. Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.
Hartel M; Narla G; Wente MN; Giese NA; Martignoni ME; Martignetti JA; Friess H; Friedman SL
Eur J Cancer; 2008 Sep; 44(13):1895-903. PubMed ID: 18691883
[TBL] [Abstract][Full Text] [Related]
10. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
12. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
13. Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes.
Mühlbauer KR; Gröne HJ; Ernst T; Gröne E; Tschada R; Hergenhahn M; Hollstein M
Br J Cancer; 2003 Aug; 89(4):687-90. PubMed ID: 12915879
[TBL] [Abstract][Full Text] [Related]
14. KLF6: mutational analysis and effect on cancer cell proliferation.
Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
[TBL] [Abstract][Full Text] [Related]
15. Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expression.
Chen CH; Huang PH; Chu PC; Chen MC; Chou CC; Wang D; Kulp SK; Teng CM; Wang Q; Chen CS
J Biol Chem; 2011 Mar; 286(12):9968-76. PubMed ID: 21282102
[TBL] [Abstract][Full Text] [Related]
16. KLF6/Sp1 initiates transcription of the tmsg-1 gene in human prostate carcinoma cells: an exon involved mechanism.
Gong M; Yu W; Pei F; You J; Cui X; McNutt MA; Li G; Zheng J
J Cell Biochem; 2012 Jan; 113(1):329-39. PubMed ID: 21928351
[TBL] [Abstract][Full Text] [Related]
17. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.
Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G
Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610
[TBL] [Abstract][Full Text] [Related]
18. [Effect of KLF6 on prostate cancer cell line PC-3 by transgenic method].
Sun M; Yang YR; Huang J; Li H; Lu YP; Wei Q; Fan TY; Li X
Zhonghua Nan Ke Xue; 2006 Jun; 12(6):502-4, 509. PubMed ID: 16833187
[TBL] [Abstract][Full Text] [Related]
19. Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35.
Shi J; Hu Z; Pabon K; Scotto KW
Mol Cell Biol; 2008 Jan; 28(2):883-95. PubMed ID: 18025108
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation.
Li D; Yea S; Dolios G; Martignetti JA; Narla G; Wang R; Walsh MJ; Friedman SL
Cancer Res; 2005 Oct; 65(20):9216-25. PubMed ID: 16230382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
